These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11457339)

  • 21. Wettability of paracetamol polymorphic forms I and II.
    Heng JY; Williams DR
    Langmuir; 2006 Aug; 22(16):6905-9. PubMed ID: 16863237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Powder Compression Properties of Paracetamol, Paracetamol Hydrochloride, and Paracetamol Cocrystals and Coformers.
    Persson AS; Ahmed H; Velaga S; Alderborn G
    J Pharm Sci; 2018 Jul; 107(7):1920-1927. PubMed ID: 29614273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental and computational growth morphology of two polymorphs of a yellow isoxazolone dye.
    Deij MA; Aret E; Boerrigter SX; van Meervelt L; Deroover G; Meekes H; Vlieg E
    Langmuir; 2005 Apr; 21(9):3831-7. PubMed ID: 15835944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Higher density does not mean higher stability" mystery of paracetamol finally unraveled.
    Nelyubina YV; Glukhov IV; Antipin MY; Lyssenko KA
    Chem Commun (Camb); 2010 May; 46(20):3469-71. PubMed ID: 20407690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystallization conditions and formation of orthorhombic paracetamol from ethanolic solution.
    Al-Zoubi N; Nikolakakis I; Malamataris S
    J Pharm Pharmacol; 2002 Mar; 54(3):325-33. PubMed ID: 11902798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined crystal structure prediction and high-pressure crystallization in rational pharmaceutical polymorph screening.
    Neumann MA; van de Streek J; Fabbiani FP; Hidber P; Grassmann O
    Nat Commun; 2015 Jul; 6():7793. PubMed ID: 26198974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphism of paracetamol: relative stabilities of the monoclinic and orthorhombic phases inferred from topological pressure-temperature and temperature-volume phase diagrams.
    Espeau P; Céolin R; Tamarit JL; Perrin MA; Gauchi JP; Leveiller F
    J Pharm Sci; 2005 Mar; 94(3):524-39. PubMed ID: 15627255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting Molecular Crystal Properties from First Principles: Finite-Temperature Thermochemistry to NMR Crystallography.
    Beran GJ; Hartman JD; Heit YN
    Acc Chem Res; 2016 Nov; 49(11):2501-2508. PubMed ID: 27754668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of additives on the growth and morphology of paracetamol (acetaminophen) crystals.
    Thompson C; Davies MC; Roberts CJ; Tendler SJ; Wilkinson MJ
    Int J Pharm; 2004 Aug; 280(1-2):137-50. PubMed ID: 15265554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structure prediction and isostructurality of three small organic halogen compounds.
    Asmadi A; Kendrick J; Leusen FJ
    Phys Chem Chem Phys; 2010 Aug; 12(30):8571-9. PubMed ID: 20532368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computing the melting point and thermodynamic stability of the orthorhombic and monoclinic crystalline polymorphs of the ionic liquid 1-n-butyl-3-methylimidazolium chloride.
    Jayaraman S; Maginn EJ
    J Chem Phys; 2007 Dec; 127(21):214504. PubMed ID: 18067361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unique mechanism of facile polymorphic conversion of acetaminophen in aqueous medium.
    Gao Y; Olsen KW
    Mol Pharm; 2014 Sep; 11(9):3056-67. PubMed ID: 25111742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From crystal structure prediction to polymorph prediction: interpreting the crystal energy landscape.
    Price SL
    Phys Chem Chem Phys; 2008 Apr; 10(15):1996-2009. PubMed ID: 18688351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect of Y Doping on Monoclinic, Orthorhombic, and Cubic Polymorphs of HfO
    Pavoni E; Mohebbi E; Mencarelli D; Stipa P; Laudadio E; Pierantoni L
    Nanomaterials (Basel); 2022 Dec; 12(23):. PubMed ID: 36500946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal morphologies and polymorphs in tolbutamide microcrystalline powder.
    Li Destri G; Marrazzo A; Rescifina A; Punzo F
    J Pharm Sci; 2013 Jan; 102(1):73-83. PubMed ID: 23042550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges of crystal structure prediction of diastereomeric salt pairs.
    Karamertzanis PG; Price SL
    J Phys Chem B; 2005 Sep; 109(36):17134-50. PubMed ID: 16853186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of the changes during heating of paracetamol.
    de Wet FN; Gerber JJ; Lötter AP; van der Watt JG; Dekker TG
    Drug Dev Ind Pharm; 1998 May; 24(5):447-53. PubMed ID: 9876607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coarse-grained modeling of crystal growth and polymorphism of a model pharmaceutical molecule.
    Mandal T; Marson RL; Larson RG
    Soft Matter; 2016 Oct; 12(39):8246-8255. PubMed ID: 27714373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modelling of crystal structure of cis-1,2,3,6 and 3,4,5,6-tetrahydrophthalic anhydrides using lattice energy calculations.
    Fredj AB; Day GM
    J Mol Model; 2015 Aug; 21(8):211. PubMed ID: 26224602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of a search technique for crystal structure prediction of flexible molecules by application to piracetam.
    Nowell H; Price SL
    Acta Crystallogr B; 2005 Oct; 61(Pt 5):558-68. PubMed ID: 16186656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.